Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Dopa and Striatal Connectivity in Schizotypy
NCT03333369Phase 1Completed
- Sponsor
- University of Zurich
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of levodopa in schizotypal personality disorder (STPD), sponsored by University of Zurich. Primary endpoint: intrinsic functional connectivity at 2 hours. Started May 2014; status: completed.
02
Drugs
levodopa
03
Conditions
schizotypal personality disorder (STPD)
Beyond the preview
Go deeper on NCT03333369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333369.